Remed Co.,Ltd. (KOSDAQ:302550)
South Korea · Delayed Price · Currency is KRW 3,750.00
-235.00 (-5.90%)
At close: Sep 19, 2025
Remed Revenue
Remed had revenue of 5.55B KRW in the quarter ending June 30, 2025, a decrease of -28.40%. This brings the company's revenue in the last twelve months to 24.48B, up 13.56% year-over-year. In the year 2024, Remed had annual revenue of 25.55B with 37.86% growth.
Revenue (ttm)
24.48B
Revenue Growth
+13.56%
P/S Ratio
4.77
Revenue / Employee
275.04M
Employees
89
Market Cap
116.65B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 25.55B | 7.02B | 37.86% |
| Dec 31, 2023 | 18.54B | -2.83B | -13.23% |
| Dec 31, 2022 | 21.36B | 1.17B | 5.79% |
| Dec 31, 2021 | 20.20B | 3.56B | 21.42% |
| Dec 31, 2020 | 16.63B | -1.92B | -10.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.59T |
| SK hynix | 77.21T |
| LG Energy Solution | 25.16T |
| Samsung Biologics | 5,031.69B |
| Hanwha Aerospace | 19.25T |
| Hyundai Motor Company | 182.25T |
| HD Hyundai Heavy Industries | 15.58T |
| KB Financial Group | 14.92T |